Zimmer Biomet (NYSE:ZBH) today announced it received FDA 510(k) clearance for its Persona Revision Knee System.
The Warsaw, Ind.-based company plans to commercially launch the knee system in the U.S. over the next few weeks.
Zimmer Biomet’s Persona knee system is designed to match a patient’s anatomy to offer a personalized fit in knee replacement procedures. The system uses the company’s Trabecular Metal technology and the Vivacit-E Highly Crosslinked Polyethylene bearing surface that protects against oxidation and maintains wear resistance and strength.
“Persona Revision completes Zimmer Biomet’s flagship Persona knee system and enhances our ecosystem of customer-centric solutions that address the needs of our customers and improve patient outcomes” president of orthopedics Ivan Tornos said in a press release. “The highly anticipated release of Persona Revision provides surgeons with a full portfolio for the continuum of knee arthroplasty care and the ability to truly tailor an implant solution based on each patient’s unique requirements.”